Eosinophilia during Hantavirus infection: a cohort study.


Journal

Infectious diseases (London, England)
ISSN: 2374-4243
Titre abrégé: Infect Dis (Lond)
Pays: England
ID NLM: 101650235

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 1 12 2021
medline: 4 5 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

There are emerging eosinophil-related considerations concerning viral infections. The role of eosinophils has poorly been evaluated during Hantavirus infection. The aim of this study was to determine the prevalence of eosinophilia (defined as an eosinophil count above 500 cells/mm Among 387 patients hospitalized for HFRS, 98 (25.3%) had eosinophilia. By univariate analysis, eosinophilia was significantly associated with more severe thrombocytopenia, high C-reactive protein level, white blood cell count and neutrophil count and lower nephrotoxic drug intake. As there was a collinearity between white blood cell count and C-reactive protein level, only C-reactive protein level with platelet count and nephrotoxic drug intake were entered in the multivariable analysis. Elevated C-reactive protein concentrations remained independently associated with eosinophilia. Eosinophilia during HFRS affects one quarter of patients, and supports the role of eosinophils in antiviral immunity against hantavirus infection.

Sections du résumé

BACKGROUND
There are emerging eosinophil-related considerations concerning viral infections. The role of eosinophils has poorly been evaluated during Hantavirus infection.
METHODS
The aim of this study was to determine the prevalence of eosinophilia (defined as an eosinophil count above 500 cells/mm
RESULTS
Among 387 patients hospitalized for HFRS, 98 (25.3%) had eosinophilia. By univariate analysis, eosinophilia was significantly associated with more severe thrombocytopenia, high C-reactive protein level, white blood cell count and neutrophil count and lower nephrotoxic drug intake. As there was a collinearity between white blood cell count and C-reactive protein level, only C-reactive protein level with platelet count and nephrotoxic drug intake were entered in the multivariable analysis. Elevated C-reactive protein concentrations remained independently associated with eosinophilia.
CONCLUSION
Eosinophilia during HFRS affects one quarter of patients, and supports the role of eosinophils in antiviral immunity against hantavirus infection.

Identifiants

pubmed: 34846983
doi: 10.1080/23744235.2021.2009129
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-282

Auteurs

Messaline Bermejo (M)

Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, Reims, France.

Stéphanie Mestrallet (S)

Department of Internal Medicine and Infectious Diseases, Manchester Hospital, Charleville-Mézières, France.

Amélie Servettaz (A)

Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, Reims, France.

Laure-Anne Pannet (LA)

Department of Internal Medicine and Infectious Diseases, Manchester Hospital, Charleville-Mézières, France.

Delphine Lebrun (D)

Department of Internal Medicine and Infectious Diseases, Manchester Hospital, Charleville-Mézières, France.

Yohan N'Guyen (Y)

Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, Reims, France.

Laurent Andreoletti (L)

Department of Virology, Reims Teaching Hospitals, Reims, France.
Reims Champagne-Ardenne University, EA-4684/SFR CAP-SANTE, Reims, France.

Jean-Marc Reynes (JM)

Centre national de référence des Hantavirus, Unité Environnement et Risques Infectieux, Institut Pasteur, Paris, France.

Maxime Hentzien (M)

Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, Reims, France.

Firouzé Bani-Sadr (F)

Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims Teaching Hospitals, Reims, France.
Reims Champagne-Ardenne University, EA-4684/SFR CAP-SANTE, Reims, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH